Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Schlomm

Showing results (71-80 of 359) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Effects of chemotherapy on the cytogenetic constitution of Wilms' tumorThorsten Schlomm, Bastian Gunawan, Hans-Jürgen Schulten, et al.
Journal of Clinical Medicine|January 8, 2025
ChatGPT as a Support Tool for Informed Consent and Preoperative Patient Education Prior to Penile Prosthesis ImplantationJacob Schmidt, Isabel Lichy, Thomas Kurz, et al.
Scientific Reports|December 23, 2024
Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancerAnja Rabien, Dezhi Rong, Silke Rabenhorst, et al.
European Urology|April 25, 2006
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy seriesJochen Walz, Markus Graefen, Felix K-H Chun, et al.
World Journal of Urology|March 1, 2006
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancerFelix K-H Chun, Markus Graefen, Mario Zacharias, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 9, 2015
PSMA expression is highly homogenous in primary prostate cancerMaria C Tsourlakis, Franka Klein, Martina Kluth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Journal of Clinical Pathology|April 6, 2013
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancersLaura Stumm, Lia Burkhardt, Stefan Steurer, et al.
The Prostate|July 17, 2015
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selectionGiorgio Gandaglia, Jonas Schiffmann, Thorsten Schlomm, et al.
European Urology|June 1, 2013
Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literatureSanoj Punnen, Matthew R Cooperberg, Anthony V D'Amico, et al.
Pageof 36

Showing results (71-80 of 359) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Effects of chemotherapy on the cytogenetic constitution of Wilms' tumorThorsten Schlomm, Bastian Gunawan, Hans-Jürgen Schulten, et al.
Journal of Clinical Medicine|January 8, 2025
ChatGPT as a Support Tool for Informed Consent and Preoperative Patient Education Prior to Penile Prosthesis ImplantationJacob Schmidt, Isabel Lichy, Thomas Kurz, et al.
Scientific Reports|December 23, 2024
Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancerAnja Rabien, Dezhi Rong, Silke Rabenhorst, et al.
European Urology|April 25, 2006
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy seriesJochen Walz, Markus Graefen, Felix K-H Chun, et al.
World Journal of Urology|March 1, 2006
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancerFelix K-H Chun, Markus Graefen, Mario Zacharias, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 9, 2015
PSMA expression is highly homogenous in primary prostate cancerMaria C Tsourlakis, Franka Klein, Martina Kluth, et al.
Proteome Science|June 24, 2010
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplificationJan C Brase, Heiko Mannsperger, Holger Fröhlich, et al.
Journal of Clinical Pathology|April 6, 2013
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancersLaura Stumm, Lia Burkhardt, Stefan Steurer, et al.
The Prostate|July 17, 2015
Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selectionGiorgio Gandaglia, Jonas Schiffmann, Thorsten Schlomm, et al.
European Urology|June 1, 2013
Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literatureSanoj Punnen, Matthew R Cooperberg, Anthony V D'Amico, et al.
Pageof 36